Damora Therapeutics (DMRA) Tax Provisions (2024 - 2026)
Damora Therapeutics (DMRA) reported Tax Provisions of $42000.0 for Q1 2026, up 2000.0% on a YoY basis from $2000.0 in Q1 2025, and down 4.55% quarter-over-quarter from $44000.0 in Q4 2025.
Damora Therapeutics (DMRA) Tax Provisions (2024 - 2026) Analysis & Trends
Damora Therapeutics has reported Tax Provisions for 3 years, with the latest figure at $42000.0 in Q1 2026.
- For the quarter ending Q1 2026, Tax Provisions rose 2000.0% year-over-year to $42000.0; the trailing twelve-month figure through Mar 2026 stood at $90000.0 (up 109.3% YoY), and the FY2025 full-year result was $50000.0, up 21.95% from the prior year.
- Tax Provisions for Q1 2026 stood at $42000.0, down from $44000.0 in the prior quarter.
- The five-year high for Tax Provisions was $44000.0 in Q4 2025, with the low at -$8000.0 in Q4 2024.
- Historically, Tax Provisions has averaged $19000.0 across 3 years, with a median of $7000.0 in 2024.
- Annual changes were most pronounced in 2025 — Tax Provisions sank 90.48% — and 2026, when it surged 2000.0%.
- Damora Therapeutics' Tax Provisions stood at -$8000.0 in 2024, then jumped by 650.0% to $44000.0 in 2025, then decreased by 4.55% to $42000.0 in 2026.
- The last three Tax Provisions figures came in at $42000.0 (Q1 2026), $44000.0 (Q4 2025), and $4000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -11.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 216,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -859,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 221.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Damora Therapeutics | 731.26 Mn | 528.86 Mn | - | 42,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 42,000.00 |
| Dec 31, 2025 | 44,000.00 |
| Jun 30, 2025 | 4,000.00 |
| Mar 31, 2025 | 2,000.00 |
| Dec 31, 2024 | -8,000.00 |
| Sep 30, 2024 | 7,000.00 |
| Jun 30, 2024 | 42,000.00 |